Aromatase Inhibitor [EPC]

72147 reported adverse events

Drugs of this class: ANASTROZOLE LETROZOLE EXEMESTANE ANASTROZOLE TABLETS LETROZOLE TABLETS

These side effects are most commonly reported by patients taking drugs of the Aromatase Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 6952
1 NAUSEA 5206
2 ARTHRALGIA 4989
3 ALOPECIA 4889
4 DIARRHOEA 4194
5 MALIGNANT NEOPLASM PROGRESSION 3753
6 PAIN 3499
7 DYSPNOEA 3281
8 NEUTROPENIA 3027
9 ASTHENIA 2883
See all common reactions for Aromatase Inhibitor [EPC]

Drugs of the Aromatase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PIK3CA-ACTIVATED MUTATION 110 0.7534
1 CARBOHYDRATE ANTIGEN 15-3 INCREASED 201 0.5180
2 CARBOHYDRATE ANTIGEN 27.29 INCREASED 42 0.4468
3 PSEUDOCIRRHOSIS 67 0.3508
4 METASTASES TO CHEST WALL 68 0.3036
5 BREAST CANCER RECURRENT 586 0.2707
6 METASTASES TO THE MEDIASTINUM 74 0.2508
7 METASTASES TO SKIN 160 0.2406
8 METASTASES TO PLEURA 141 0.2311
9 BREAST CANCER METASTATIC 1689 0.2278
See all enriched reactions for Aromatase Inhibitor [EPC]